Both Europe and India started off with a distributor model which is basically at zero cost to the company.
We invested heavily in getting quality sales staff up and running in the States and Aus/NZ and both regions are now starting to ramp up after access to hospitals opened up again and recognition of the benefits of the product has become more widespread.
The distributor model obviously hasn’t worked and is now being replaced by direct sales teams.
Let’s see how that goes hey.
4 mil market in 4 years??? We have that on record
Ann: PolyNovo enters India market, page-161
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.48 |
Change
0.125(5.32%) |
Mkt cap ! $1.712B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.52 | $2.38 | $4.433M | 1.798M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 19428 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 15051 | 26 |
View Market Depth
| Last trade - 14.24pm 10/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |